Eversept Partners, LP Biogen Inc. Transaction History

Eversept Partners, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 08, 2023	BUY	$256.56 - $292.34 $4.21 Million - $4.8 Million	16,426 Added 11.96%	153,774 $42.8 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $4.21 Million - $4.8 Million	16,426 Added 11.96%	153,774 $42.8 Million
Q4 2022 Nov 08, 2023	BUY	$252.44 - $306.72 $19.5 Million - $23.7 Million	77,204 Added 128.37%	137,348 $38 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $19.5 Million - $23.7 Million	77,204 Added 128.37%	137,348 $38 Million
Q3 2022 Nov 08, 2023	SELL	$194.69 - $268.46 $8.03 Million - $11.1 Million	-41,270 Reduced 40.69%	60,144 $16.1 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $8.03 Million - $11.1 Million	-41,270 Reduced 40.69%	60,144 $16.1 Million
Q2 2022 Nov 08, 2023	BUY	$187.54 - $223.02 $4.39 Million - $5.22 Million	23,411 Added 30.01%	101,414 $20.7 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $4.39 Million - $5.22 Million	23,411 Added 30.01%	101,414 $20.7 Million
Q1 2022 Nov 08, 2023	BUY	$193.77 - $244.14 $15.1 Million - $19 Million	78,003 New	78,003 $16.4 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $8.71 Million - $11 Million	44,962 Added 136.08%	78,003 $16.4 Million
Q4 2021 Nov 08, 2023	BUY	$223.92 - $287.77 $7.4 Million - $9.51 Million	33,041 New	33,041 $7.93 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $7.4 Million - $9.51 Million	33,041 New	33,041 $7.93 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.